Iovance Biotherapeutics, Inc. IOVA Book value per share

Book value per share at other companies

Gilead SciencesGILD

$9.52-39.3%

ImmunityBio, Inc.IBRX

-$0.85-22.2%

CTO

Citius Oncology, Inc.CTOR

$0.35-29.2%

Cullinan Therapeutics, Inc.CGEM

$10.76-1.9%

Artiva Biotherapeutics, Inc.ARTV

$8.82+44.2%

IncyteINCY

$30.47+45.2%

FAQ

What is Iovance Biotherapeutics, Inc.'s book value per share?

Iovance Biotherapeutics, Inc. (IOVA) reported book value per share of $1.64 in Q2 2026.

How has Iovance Biotherapeutics, Inc.'s book value per share changed year-over-year?

Iovance Biotherapeutics, Inc.'s book value per share decreased by 21.7% year-over-year, from $2.09 to $1.64.

What is the long-term trend for Iovance Biotherapeutics, Inc.'s book value per share?

Over 5 years (2020 to 2025), Iovance Biotherapeutics, Inc.'s book value per share has grown at a -15.3% compound annual growth rate (CAGR), from $4.47 to $1.95.

What does book value per share mean?

Shareholders' equity divided by diluted shares outstanding at the quarter end. The accounting (book) value attributable to each share.